Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$27,000.00
Exploring the Role of Extracellular Granzyme B in Pterygium
EF 2024-25
Résumé
Pterygium is an overgrowth of the conjunctiva, the protective layer on the surface of the eye, that can cause irritation, dryness, and damage to the cornea;the window of the eye;ultimately impairing vision. Primarily caused by ultraviolet (UV) light from the sun, pterygium affects millions of people worldwide. With no available drug therapies, surgery is the primary treatment option. However, managing pterygium is challenging due to its high recurrence rate after surgery, which increases the risk of complications and places a significant burden on healthcare systems.Granzyme B (GrB) is a protein released by various cells across different organs, acting as a molecular scissor to enter and kill infected or damaged cells. While its protective role is well-established, excessive GrB activity outside of cells has been linked to the onset and progression of several diseases by promoting inflammation and tissue damage. Notably, elevated levels of GrB are frequently observed in tissues exposed to UV light.Our preliminary findings indicate that post-mortem human donor eyes with pterygium exhibit significantly higher levels of GrB compared to healthy eyes. To further explore GrB as a therapeutic target for pterygium, this project will analyze fresh tissues collected during surgery to: 1) measure GrB levels in pterygium and healthy conjunctiva, 2) identify its cellular sources, and 3) examine GrB direct impact on conjunctival cells in the laboratory. This project will uncover the complex mechanisms underlying pterygium and encourage the development of drug-based therapies. Additionally, given GrB involvement in various diseases;including immune, neurodegenerative, and cancer-related conditions;this research will provide broader insights and be of use to many researchers.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
529963
Name
Hosseini Amirali
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring the Role of Extracellular Granzyme B in Pterygium
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cell Culture; Conjunctiva; Cornea; Extracellular Granzyme B; Fibrosis; Immune Cells; Immunohistochemistry; Ocular Surface; Ocular Surface Squamous Neoplasia; Pterygium
Abstract
Pterygium is an overgrowth of the conjunctiva, the protective layer on the surface of the eye, that can cause irritation, dryness, and damage to the cornea;the window of the eye;ultimately impairing vision. Primarily caused by ultraviolet (UV) light from the sun, pterygium affects millions of people worldwide. With no available drug therapies, surgery is the primary treatment option. However, managing pterygium is challenging due to its high recurrence rate after surgery, which increases the risk of complications and places a significant burden on healthcare systems.Granzyme B (GrB) is a protein released by various cells across different organs, acting as a molecular scissor to enter and kill infected or damaged cells. While its protective role is well-established, excessive GrB activity outside of cells has been linked to the onset and progression of several diseases by promoting inflammation and tissue damage. Notably, elevated levels of GrB are frequently observed in tissues exposed to UV light.Our preliminary findings indicate that post-mortem human donor eyes with pterygium exhibit significantly higher levels of GrB compared to healthy eyes. To further explore GrB as a therapeutic target for pterygium, this project will analyze fresh tissues collected during surgery to: 1) measure GrB levels in pterygium and healthy conjunctiva, 2) identify its cellular sources, and 3) examine GrB direct impact on conjunctival cells in the laboratory. This project will uncover the complex mechanisms underlying pterygium and encourage the development of drug-based therapies. Additionally, given GrB involvement in various diseases;including immune, neurodegenerative, and cancer-related conditions;this research will provide broader insights and be of use to many researchers.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hosseini, Amirali
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~